AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Absci Corporation Common Stock
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG011N54DC3
9.18▼ 0.19 (-2.03%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
9.37
Day's Range
8.97 – 9.35
52-Week Range
2.24 – 12.06
Volume
1.8M
Avg Volume
4.2M
Share Statistics
Shares Outstanding
Employees
140
Exchange
XNAS
Listed
2021-07-22
Share count as of July 31, 2026

Absci Corporation Common Stock (ABSI) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Absci Corporation Common Stock (ABSI)
What is Absci Corporation Common Stock's Market Cap?
Absci Corporation Common Stock's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Absci Corporation Common Stock's Price / Sales?
Absci Corporation Common Stock's Price / Sales is 1009.2×, based on as-reported figures from SEC (XBRL) filings.
What is Absci Corporation Common Stock's Revenue (TTM)?
Absci Corporation Common Stock's Revenue (TTM) is $1.6M, based on as-reported figures from SEC (XBRL) filings.
What is Absci Corporation Common Stock's Net Income (TTM)?
Absci Corporation Common Stock's Net Income (TTM) is -$121.1M, based on as-reported figures from SEC (XBRL) filings.
What is Absci Corporation Common Stock's EBITDA?
Absci Corporation Common Stock's EBITDA is -$115.1M, based on as-reported figures from SEC (XBRL) filings.
What is Absci Corporation Common Stock's Diluted EPS (TTM)?
Absci Corporation Common Stock's Diluted EPS (TTM) is -0.71, based on as-reported figures from SEC (XBRL) filings.
What is Absci Corporation Common Stock's EBITDA Margin?
Absci Corporation Common Stock's EBITDA Margin is -7373.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ABSIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Partner program revenue
YoY growth-46.4%-81.8%-2.3%-77.8%
Operating expenses
Research and development
Selling, general and administrative
Depreciation and amortization
Total operating expenses
% of revenue10841.5%14447.0%4875.5%8077.2%
Operating loss
% of revenue-10741.5%-14347.0%-4775.5%-7977.2%
Other income (expense)
Interest expense
Other income, net
Total other income, net
Loss before income taxes
Income tax expense
Net loss
% of revenue-10443.4%-13767.0%-4548.0%-7594.2%
Net loss per share: basic (in usd per share)—
Net loss per share: diluted (in usd per share)—